Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.

Crozat A, Aman P, Mandahl N, Ron D.

Nature. 1993 Jun 17;363(6430):640-4.

PMID:
8510758
2.
3.

Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma.

Kuroda M, Ishida T, Horiuchi H, Kida N, Uozaki H, Takeuchi H, Tsuji K, Imamura T, Mori S, Machinami R, et al.

Am J Pathol. 1995 Nov;147(5):1221-7.

4.

Fusion of the EWS and CHOP genes in myxoid liposarcoma.

Panagopoulos I, Höglund M, Mertens F, Mandahl N, Mitelman F, Aman P.

Oncogene. 1996 Feb 1;12(3):489-94.

PMID:
8637704
5.
6.

Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.

Antonescu CR, Elahi A, Healey JH, Brennan MF, Lui MY, Lewis J, Jhanwar SC, Woodruff JM, Ladanyi M.

Clin Cancer Res. 2000 Jul;6(7):2788-93.

7.

FUS/TLS-CHOP chimeric transcripts in liposarcoma tissues.

Yang X, Nagasaki K, Egawa S, Maruyama K, Futami H, Tsukada T, Yokoyama R, Beppu Y, Fukuma H, Shimoda T, et al.

Jpn J Clin Oncol. 1995 Dec;25(6):234-9.

PMID:
8523819
9.

Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation.

Kanoe H, Nakayama T, Hosaka T, Murakami H, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Ron D, Sasaki MS, Toguchida J.

Oncogene. 1999 Jan 21;18(3):721-9.

10.
11.

A rare chimeric TLS/FUS-CHOP transcript in a patient with multiple liposarcomas: a case report.

Schneider-Stock R, Rys J, Walter H, Limon J, Iliszko M, Niezabitowski A, Roessner A.

Cancer Genet Cytogenet. 1999 Jun;111(2):130-3.

PMID:
10347549
12.

Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues.

Hisaoka M, Tsuji S, Morimitsu Y, Hashimoto H, Shimajiri S, Komiya S, Ushijima M.

Diagn Mol Pathol. 1998 Apr;7(2):96-101.

PMID:
9785008
13.

Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11).

Aman P, Ron D, Mandahl N, Fioretos T, Heim S, Arheden K, Willén H, Rydholm A, Mitelman F.

Genes Chromosomes Cancer. 1992 Nov;5(4):278-85.

PMID:
1283316
14.

RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells.

Rapp TB, Yang L, Conrad EU 3rd, Mandahl N, Chansky HA.

J Orthop Res. 2002 Jul;20(4):723-9.

15.

A novel FUS/CHOP chimera in myxoid liposarcoma.

Panagopoulos I, Mertens F, Isaksson M, Mandahl N.

Biochem Biophys Res Commun. 2000 Dec 29;279(3):838-45.

PMID:
11162437
16.

Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins.

Morohoshi F, Arai K, Takahashi EI, Tanigami A, Ohki M.

Genomics. 1996 Nov 15;38(1):51-7.

PMID:
8954779
17.

Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma.

Pérez-Losada J, Sánchez-Martín M, Rodríguez-García MA, Pérez-Mancera PA, Pintado B, Flores T, Battaner E, Sánchez-Garćia I.

Oncogene. 2000 Dec 7;19(52):6015-22.

18.

Genomic PCR detects tumor cells in peripheral blood from patients with myxoid liposarcoma.

Panagopoulos I, Aman P, Mertens F, Mandahl N, Rydholm A, Bauer HF, Mitelman F.

Genes Chromosomes Cancer. 1996 Oct;17(2):102-7.

PMID:
8913727
19.

Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein.

Kuroda M, Ishida T, Takanashi M, Satoh M, Machinami R, Watanabe T.

Am J Pathol. 1997 Sep;151(3):735-44.

Supplemental Content

Support Center